Kavanagh B P, Cheng D C, Sandler A N, Chung F, Lawson S, Ong D
Department of Anaesthesia, University of Toronto, Toronto Hospital (General and Western Divisions), Ontario, Canada.
Anesth Analg. 1993 May;76(5):950-6. doi: 10.1213/00000539-199305000-00006.
This randomized, prospective clinical study investigated the effects of supplemental inspired oxygen on arterial hemoglobin desaturation and myocardial ischemia in premedicated patients who have critical coronary artery stenosis, identified predictors for these adverse events, and examined the temporal relationship between hemoglobin desaturation and myocardial ischemia. Before elective coronary artery bypass surgery, 104 patients were monitored continuously by using a real-time electrocardiogram (V4 and V5 leads) recorder and a digital pulse oximeter. After a 2-h baseline monitoring period (Interval A), patients were given sublingual lorazepam 0.03 mg/kg, and were randomized to receive continuous supplemental inspired oxygen by nasal catheters [4 L/min (Oxygen Group, n = 52)] or to receive no supplemental inspired oxygen (Control Group, n = 52) (Interval B). One hour later, all patients received intramuscular morphine 0.15 mg/kg with perphenazine 0.05 mg/kg (Interval C). Interval C lasted 1 h, and the study was terminated. In the Oxygen Group, the incidence of desaturation was 25% before premedication and 11.5% after premedication (NS). In the Control Group after premedication, the incidence of desaturation increased from 25% to 56.9% (P < 0.001). There was no significant difference in the incidence of myocardial ischemia before or after premedication within or between the two groups. Arterial hemoglobin desaturation was not associated temporally with myocardial ischemia at any time. Predictors of desaturation after premedication included absence of supplemental O2, increased weight, age, and occurrence of desaturation before premedication. There were no identifiable predictors for myocardial ischemia after premedication. During Intervals A and C, episodes of hemoglobin desaturation were associated with small but statistically significant increases in mean heart rate.(ABSTRACT TRUNCATED AT 250 WORDS)
这项随机、前瞻性临床研究调查了补充吸入氧气对患有严重冠状动脉狭窄的术前用药患者动脉血红蛋白去饱和及心肌缺血的影响,确定了这些不良事件的预测因素,并研究了血红蛋白去饱和与心肌缺血之间的时间关系。在择期冠状动脉搭桥手术前,使用实时心电图(V4和V5导联)记录仪和数字脉搏血氧仪对104例患者进行连续监测。在2小时的基线监测期(A期)后,给患者舌下含服0.03mg/kg劳拉西泮,然后随机分为通过鼻导管接受持续补充吸入氧气[4L/分钟(氧气组,n=52)]或不接受补充吸入氧气(对照组,n=52)(B期)。1小时后,所有患者肌肉注射0.15mg/kg吗啡和0.05mg/kg奋乃静(C期)。C期持续1小时,研究结束。在氧气组,术前去饱和发生率为25%,术前用药后为11.5%(无统计学意义)。在对照组术前用药后,去饱和发生率从25%增加到56.9%(P<0.001)。两组内及两组间术前用药前后心肌缺血发生率无显著差异。动脉血红蛋白去饱和在任何时候与心肌缺血均无时间相关性。术前用药后去饱和的预测因素包括未补充氧气、体重增加、年龄及术前去饱和的发生。术前用药后心肌缺血无可识别的预测因素。在A期和C期,血红蛋白去饱和发作与平均心率的小幅但有统计学意义的增加相关。(摘要截短于250字)